Sepsis is life threatening complication caused due to the infection, which can result into organ failure, tissue damage, and ultimately lead to death if left untreated. If sepsis progresses to septic shock, it cause sudden drop in blood pressure and may leads to death of patient. Sepsis occurs due the infection in any part of the body. However the most common site of infections leading to the sepsis are lungs, abdomen, pelvis, and urinary tract.

Patients suffering from impaired immune system due to illness or drugs, cancer treatment with chemotherapy, splenectomy, sickle cell disease, and people who consume steroids and immunosuppressant drugs are prone to sepsis. The symptoms associated with sepsis includes high fever with temperature above 1010 F or temperature below 96.8 F, increased heart rate to 90 beats per minute, high breathing rate to around 20 breaths per minute, tissue swelling and confirmed infection. According to the Healthcare Cost and Utilization Project (HCUP) report submitted by Agency for Healthcare Research and Quality (AHRQ) in 2016, septicemia accounted for the leading cause of hospitalization in the U.S., owing to consuming more than US$ 24 billion each year.

Get Sample Copy Here: https://www.coherentmarketinsights.com/insight/request-sample/1166
Sepsis Diagnostic Market Taxonomy:
On the basis of product, sepsis diagnostic market segmented into:
• Assay and reagents
• Blood culture media
• Instruments
• Others
On the basis of pathogen, sepsis diagnostic market segmented into:
• Fungal sepsis
• Bacterial sepsis
◦ Gram-positive bacterial sepsis
◦ Gram-negative bacterial sepsis
• Other infectious pathogens
On the basis of methods, sepsis diagnostic market segmented into:
• Immunoassays
• Flow cytometry
• Molecular diagnosis
• Biomarker diagnosis
On the basis of diagnostic method, sepsis diagnostic market segmented into:
• Conventional diagnostic methods
• Automated diagnostic methods
On the basis of end user, sepsis diagnostic market segmented into:
• Hospital laboratories
• Diagnostic & Pathology laboratories
• Academic and research laboratories
• Other end users

Key players in the sepsis diagnostic market:
Some of the key players operating in the sepsis diagnostic market includes BioMerieux SA, Cepheid, Thermo Fisher Scientific Inc., T2 Biosystems, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche Ltd, Luminex Corporation, Becton, Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc.
To Get Instant Access, Purchase Report Here: https://www.coherentmarketinsights.com/insight/buy-now/1166
In February 2017 Immunexpress a technology based company provides solutions for sepsis diagnostics, received U.S. Food and Drug Administration approval for the SeptiCyte test as an aid in differentiating patients that have sepsis caused due to systemic inflammatory response syndrome (SIRS)


About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: [email protected]